These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25916031)

  • 1. New measles vaccination schedules in the European countries?
    Allam MF
    J Prev Med Hyg; 2014 Mar; 55(1):33-4. PubMed ID: 25916031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles outbreak in Europe: susceptibility of infants too young to be immunized.
    Leuridan E; Sabbe M; Van Damme P
    Vaccine; 2012 Sep; 30(41):5905-13. PubMed ID: 22841972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal age for vaccination against measles in the State of São Paulo, Brazil, taking into account the mother's serostatus.
    Zanetta RA; Amaku M; Azevedo RS; Zanetta DM; Burattini MN; Massad E
    Vaccine; 2001 Oct; 20(1-2):226-34. PubMed ID: 11567768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age.
    De Serres G; Boulianne N; Defay F; Brousseau N; Benoît M; Lacoursière S; Guillemette F; Soto J; Ouakki M; Ward BJ; Skowronski DM
    Clin Infect Dis; 2012 Aug; 55(3):394-402. PubMed ID: 22543023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protecting the vaccinating population in the face of a measles epidemic: assessing the impact of adjusted vaccination schedules.
    van den Hof S; Wallinga J; Widdowson MA; Conyn-van Spaendonck MA
    Epidemiol Infect; 2002 Feb; 128(1):47-57. PubMed ID: 11895090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-dose measles vaccination schedules.
    Rosenthal SR; Clements CJ
    Bull World Health Organ; 1993; 71(3-4):421-8. PubMed ID: 8324862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles vaccination policy.
    Williams BG; Cutts FT; Dye C
    Epidemiol Infect; 1995 Dec; 115(3):603-21. PubMed ID: 8557092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles in Europe: an epidemiological assessment.
    Muscat M; Bang H; Wohlfahrt J; Glismann S; Mølbak K;
    Lancet; 2009 Jan; 373(9661):383-9. PubMed ID: 19131097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles vaccine effectiveness in standard and early immunization strategies, Niger, 1995.
    Kaninda AV; Legros D; Jataou IM; Malfait P; Maisonneuve M; Paquet C; Moren A
    Pediatr Infect Dis J; 1998 Nov; 17(11):1034-9. PubMed ID: 9849988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two doses of measles vaccine: are some states in India ready for it?
    John S; Sanghi S; Prasad S; Bose A; George K
    J Trop Pediatr; 2009 Aug; 55(4):253-6. PubMed ID: 18799515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles outbreaks prompt pediatrics academy to call for two-dose immunization schedule.
    Clin Pharm; 1989 Nov; 8(11):760-1. PubMed ID: 2805627
    [No Abstract]   [Full Text] [Related]  

  • 13. Should outbreak response immunization be recommended for measles outbreaks in middle- and low-income countries? An update.
    Cairns KL; Perry RT; Ryman TK; Nandy RK; Grais RF
    J Infect Dis; 2011 Jul; 204 Suppl 1():S35-46. PubMed ID: 21666184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is measles elimination possible in WHO European region up to 2015?
    Paslawska A; Mrozek-Budzyn D
    Przegl Epidemiol; 2013; 67(3):451-4, 553-5. PubMed ID: 24340559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The significance of epidemiological studies for progress of measles elimination].
    Mrozek-Budzyn D
    Przegl Epidemiol; 2010; 64(3):361-6. PubMed ID: 20976947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward measles elimination--European Region, 2005--2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(6):142-5. PubMed ID: 19229166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving our strategy to prevent and control measles outbreaks.
    Gravatt L
    N Z Med J; 2015 Jun; 128(1416):84-6. PubMed ID: 26117683
    [No Abstract]   [Full Text] [Related]  

  • 18. Why we should vaccinate early for measles.
    Roth R
    J Fam Pract; 2019 May; 68(4):193-194. PubMed ID: 31287450
    [No Abstract]   [Full Text] [Related]  

  • 19. Passive immunity against measles in infants: is there a need for policy changes in the European vaccination schedules?
    Johansen K; Lopalco P
    Euro Surveill; 2007 Sep; 12(9):E3-4. PubMed ID: 17991415
    [No Abstract]   [Full Text] [Related]  

  • 20. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.